Increased activity of the mannan‐binding lectin complement activation pathway in patients with colorectal cancer

References

• Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg 2000;87:1553–62.
   Google Scholar
• Kressner U, Graf W, Mahteme H, Pahlman L, Glimelius B. Septic complications and prognosis after surgery for rectal cancer. Dis Colon Rectum 2002;45:316–21.
   Google Scholar
• Grandis JR, Snyderman CH, Johnson JT, Yu VL, D’Amico F. Postoperative wound infection. A poor prognostic sign for patients with head and neck cancer. Cancer 1992;70:2166–70.
   Google Scholar
• Swisher SG, Holmes EC, Hunt KK, Gornbein JA, Zinner MJ, McFadden DW. Perioperative blood transfusions and decreased long-term survival in esophageal cancer. J Thorac Cardiovasc Surg 1996;112:341–8.
   PubMedGoogle Scholar
• Herroeder S, Durieux ME, Hollmann MW. Inflammatory responses after surgery. Hosp Med 2002;63:99–103.
   Google Scholar
• Kehlet H, Nielsen HJ. Impact of laparoscopic surgery on stress responses, immunofunction, and risk of infectious complications. New Horiz 1998;6 Suppl 2:S80–S8.
   Google Scholar
• Windsor AC, Klava A, Somers SS, Guillou PJ, Reynolds JV. Manipulation of local and systemic host defence in the prevention of perioperative sepsis. Br J Surg 1995;82:1460–7.
   Google Scholar
• Faist E. The mechanisms of host defense dysfunction following shock and trauma. Curr Top Microbiol Immunol 1996;216:259–74.
   PubMedGoogle Scholar
• Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injury. J Am Coll Surg 2001;193:237–44.
   PubMed Web of Science ®Google Scholar
• Holmskov U, Thiel S, Jensenius JC. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2003;21:547–78.
   PubMed Web of Science ®Google Scholar
• Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001;38:133–49.
   Google Scholar
• Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannosebinding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001;358 (9282):614–8.
   PubMedGoogle Scholar
• Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001;358 (9282):637–8.
   PubMed Web of Science ®Google Scholar
• Zimmermann-Nielsen E, Baatrup G, Thorlacius-Ussing O, Agnholt J, Svehag SE. Complement activation mediated by mannan-binding lectin in plasma from healthy individuals and from patients with SLE, Crohn’s disease and colorectal cancer. Suppressed activation by SLE plasma. Scand J Immunol 2002; 55:105–10.
   Google Scholar
• Christiansen OB, Kilpatrick DC, Souter V, Varming K, Thiel S, Jensenius JC. Mannan-binding lectin deficiency is associated with unexplained recurrent miscarriage. Scand J Immunol 1999; 49:193–6.
   PubMed Web of Science ®Google Scholar
• Thiel S, Moller-Kristensen M, Jensen L, Jensenius JC. Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Immunobiology 2002;205:446–54.
   PubMed Web of Science ®Google Scholar
• Petersen SV, Thiel S, Jensen L, Steffensen R, Jensenius JC. An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods 2001;257:107–16.
   Google Scholar
• Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 1992;90:31–5.
   Google Scholar
• Liu H, Jensen L, Hansen S, Petersen SV, Takahashi K, Ezekowitz AB, et al. Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses. Scand J Immunol 2001;53:489–97.
   PubMedGoogle Scholar
• Bergmann OJ, Christiansen M, Laursen I, Bang P, Hansen NE, Ellegaard J, Koch C, Andersen V. Low levels of mannosebinding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 2003;70:91–7.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Hansen U, Christensen IJ, Reimert CM, Brunner N, Moesgaard F. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 1999; 189:487–95.
   PubMed Web of Science ®Google Scholar
• Terai I, Kobayashi K, Fujita T, Hagiwara K. Human serum mannose binding protein (MBP): development of an enzyme-linked immunosorbent assay (ELISA) and determination of levels in serum from 1085 normal Japanese and in some body fluids. Biochem Med Metab Biol 1993;50:111–9.
   PubMedGoogle Scholar
• Garred P, Strom J, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003;188:1394–403.
   Google Scholar
• Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet 1995;346 (8980):941–3.
   PubMedGoogle Scholar
• Summerfield JA, Ryder S, Sumiya M, Thursz M, Gorchein A, Monteil MA, et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995;345 (8954):886–9.
   PubMedGoogle Scholar
• Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. Br Med J 1997; 314: 1229–32.
   PubMed Web of Science ®Google Scholar
• Turner MW, Hamvas RM. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2000;2:305–22.
   PubMedGoogle Scholar
• Tonnesen H, Petersen KR, Hojgaard L, Stokholm KH, Nielsen HJ, Knigge U, et al. Postoperative morbidity among symptomfree alcohol misusers. Lancet 1992;340 (8815):334–7.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ. The effect of histamine type-2 receptor antagonists on posttraumatic immune competence. Dan Med Bull 1995;42: 162–74.
   PubMedGoogle Scholar
• Guillou PJ. Biological variation in the development of sepsis after surgery or trauma. Lancet 1993;342 (8865):217–20.
   PubMedGoogle Scholar